New Point-of-Care Assay Platform Diagnosis Cardiovascular Diseases at Home
Neuome Peptides Pte. established an assay-development platform for the quantifiable detection of biomarkers.
Read MorePosted by Andy Lundin | Dec 19, 2022 | Cardiovascular |
Neuome Peptides Pte. established an assay-development platform for the quantifiable detection of biomarkers.
Read MorePosted by Andy Lundin | Dec 9, 2022 | Covid 19 |
Wastewater epidemiology can track the types of chemicals and viruses in sewers as a public data tool for public health and safety policies.
Read MorePosted by Andy Lundin | Dec 6, 2022 | Dementias & Alzheimer’s, Diabetes & Metabolic Diseases |
A scientist is developing health information tech designed to enhance accessibility and value to adults with diabetes and Alzheimer’s disease.
Read MorePosted by Andy Lundin | Nov 24, 2022 | Diabetes & Metabolic Diseases |
Using a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read MorePosted by Andy Lundin | Nov 15, 2022 | Diabetes & Metabolic Diseases, Kidney Disease |
A personalized approach to kidney disease screening for type 1 diabetes patients may reduce the time chronic kidney disease goes undetected.
Read More